These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 34051148)

  • 1. Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease.
    Bergamaschi L; Mescia F; Turner L; Hanson AL; Kotagiri P; Dunmore BJ; Ruffieux H; De Sa A; Huhn O; Morgan MD; Gerber PP; Wills MR; Baker S; Calero-Nieto FJ; Doffinger R; Dougan G; Elmer A; Goodfellow IG; Gupta RK; Hosmillo M; Hunter K; Kingston N; Lehner PJ; Matheson NJ; Nicholson JK; Petrunkina AM; Richardson S; Saunders C; Thaventhiran JED; Toonen EJM; Weekes MP; ; Göttgens B; Toshner M; Hess C; Bradley JR; Lyons PA; Smith KGC
    Immunity; 2021 Jun; 54(6):1257-1275.e8. PubMed ID: 34051148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal Analysis of Human Memory T-Cell Response According to the Severity of Illness up to 8 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Kang CK; Kim M; Lee S; Kim G; Choe PG; Park WB; Kim NJ; Lee CH; Kim IS; Jung K; Lee DS; Shin HM; Kim HR; Oh MD
    J Infect Dis; 2021 Jul; 224(1):39-48. PubMed ID: 33755725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients.
    Notarbartolo S; Ranzani V; Bandera A; Gruarin P; Bevilacqua V; Putignano AR; Gobbini A; Galeota E; Manara C; Bombaci M; Pesce E; Zagato E; Favalli A; Sarnicola ML; Curti S; Crosti M; Martinovic M; Fabbris T; Marini F; Donnici L; Lorenzo M; Mancino M; Ungaro R; Lombardi A; Mangioni D; Muscatello A; Aliberti S; Blasi F; De Feo T; Prati D; Manganaro L; Granucci F; Lanzavecchia A; De Francesco R; Gori A; Grifantini R; Abrignani S
    Sci Immunol; 2021 Aug; 6(62):. PubMed ID: 34376481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrin Activation Enables Sensitive Detection of Functional CD4
    Schöllhorn A; Schuhmacher J; Besedovsky L; Fendel R; Jensen ATR; Stevanović S; Lange T; Rammensee HG; Born J; Gouttefangeas C; Dimitrov S
    Front Immunol; 2021; 12():626308. PubMed ID: 33854501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional Changes in CD16+ Monocytes May Contribute to the Pathogenesis of COVID-19.
    Chilunda V; Martinez-Aguado P; Xia LC; Cheney L; Murphy A; Veksler V; Ruiz V; Calderon TM; Berman JW
    Front Immunol; 2021; 12():665773. PubMed ID: 34108966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypes and Functions of SARS-CoV-2-Reactive T Cells.
    Jung MK; Shin EC
    Mol Cells; 2021 Jun; 44(6):401-407. PubMed ID: 34120892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological Biomarkers of COVID-19.
    Lei R; Mohan C
    Crit Rev Immunol; 2020; 40(6):497-512. PubMed ID: 33900694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative Clinical Evolution in COVID-19 Patients Is Frequently Accompanied With an Increased Proportion of Undifferentiated Th Cells and a Strong Underrepresentation of the Th1 Subset.
    Gutiérrez-Bautista JF; Rodriguez-Nicolas A; Rosales-Castillo A; Jiménez P; Garrido F; Anderson P; Ruiz-Cabello F; López-Ruz MÁ
    Front Immunol; 2020; 11():596553. PubMed ID: 33324414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophages and Dendritic Cells Are Not the Major Source of Pro-Inflammatory Cytokines Upon SARS-CoV-2 Infection.
    Niles MA; Gogesch P; Kronhart S; Ortega Iannazzo S; Kochs G; Waibler Z; Anzaghe M
    Front Immunol; 2021; 12():647824. PubMed ID: 34122407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signature of long-lived memory CD8
    Adamo S; Michler J; Zurbuchen Y; Cervia C; Taeschler P; Raeber ME; Baghai Sain S; Nilsson J; Moor AE; Boyman O
    Nature; 2022 Feb; 602(7895):148-155. PubMed ID: 34875673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction and exhausted features of T lymphocytes under serological changes, and prognostic factors in COVID-19 progression.
    Mahmoodpoor A; Hosseini M; Soltani-Zangbar S; Sanaie S; Aghebati-Maleki L; Saghaleini SH; Ostadi Z; Hajivalili M; Bayatmakoo Z; Haji-Fatahaliha M; Babaloo Z; Farid SS; Heris JA; Roshangar L; Rikhtegar R; Kafil HS; Yousefi M
    Mol Immunol; 2021 Oct; 138():121-127. PubMed ID: 34392110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning.
    Patterson BK; Guevara-Coto J; Yogendra R; Francisco EB; Long E; Pise A; Rodrigues H; Parikh P; Mora J; Mora-Rodríguez RA
    Front Immunol; 2021; 12():700782. PubMed ID: 34262570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19: Risk Factors Associated with Infectivity and Severity.
    Fadl N; Ali E; Salem TZ
    Scand J Immunol; 2021 Jun; 93(6):e13039. PubMed ID: 33710663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Co-inhibitory Receptor Expression in COVID-19 Infection Compared to Acute
    Herrmann M; Schulte S; Wildner NH; Wittner M; Brehm TT; Ramharter M; Woost R; Lohse AW; Jacobs T; Schulze Zur Wiesch J
    Front Immunol; 2020; 11():1870. PubMed ID: 32983106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential T-Cell Reactivity to Endemic Coronaviruses and SARS-CoV-2 in Community and Health Care Workers.
    da Silva Antunes R; Pallikkuth S; Williams E; Dawen Yu E; Mateus J; Quiambao L; Wang E; Rawlings SA; Stadlbauer D; Jiang K; Amanat F; Arnold D; Andrews D; Fuego I; Dan JM; Grifoni A; Weiskopf D; Krammer F; Crotty S; Hoffer ME; Pahwa SG; Sette A
    J Infect Dis; 2021 Jul; 224(1):70-80. PubMed ID: 33822097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lasting Changes to Circulating Leukocytes in People with Mild SARS-CoV-2 Infections.
    Kennedy AE; Cook L; Breznik JA; Cowbrough B; Wallace JG; Huynh A; Smith JW; Son K; Stacey H; Ang J; McGeer A; Coleman BL; Larché M; Larché M; Hambly N; Nair P; Ask K; Miller MS; Bramson J; Levings MK; Nazy I; Svenningsen S; Mukherjee M; Bowdish DME
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Cytokine Profiles and Immune Response Are Increased in COVID-19 Patients with Type 2 Diabetes Mellitus.
    Zheng M; Wang X; Guo H; Fan Y; Song Z; Lu Z; Wang J; Zheng C; Dong L; Ma Y; Zhu Y; Fang H; Ye S
    J Diabetes Res; 2021; 2021():9526701. PubMed ID: 33490288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T Cells as Predictors of Clinical Course in Hospitalised COVID-19 Patients.
    Caldrer S; Mazzi C; Bernardi M; Prato M; Ronzoni N; Rodari P; Angheben A; Piubelli C; Tiberti N
    Front Immunol; 2021; 12():789735. PubMed ID: 34925369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte Changes in Severe COVID-19: Delayed Over-Activation of STING?
    Berthelot JM; Lioté F; Maugars Y; Sibilia J
    Front Immunol; 2020; 11():607069. PubMed ID: 33335532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.
    Lafon E; Diem G; Witting C; Zaderer V; Bellmann-Weiler RM; Reindl M; Bauer A; Griesmacher A; Fux V; Hoermann G; Miller C; Zabernigg A; Wöll E; Wilflingseder D; Lass-Flörl C; Posch W
    Front Immunol; 2021; 12():684014. PubMed ID: 34194438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.